HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

BACKGROUND: Despite a typically good response to first-line combination chemotherapy, the prognosis for patients with advanced ovarian cancer remains poor because of acquired chemoresistance. The use of targeted therapies such as trastuzumab may potentially improve outcomes for patients with ovarian...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tuefferd, Marianne, Couturier, Jérôme, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Broët, Philippe, Guastalla, Jean-Paul, Allouache, Djelila, Combe, Martin, Weber, Béatrice, Pujade-Lauraine, Eric, Camilleri-Broët, Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2007
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042515/
https://ncbi.nlm.nih.gov/pubmed/17987122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0001138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados